VIDAS® Lyme panel

Differential diagnosis of Lyme Borreliosis

The combined use of the automated VIDAS® Lyme IgM and VIDAS® Lyme IgG assays will help you provide patients with reliable, differential diagnosis of Lyme borreliosis in just 27 minutes.

  • Clear-cut results
  • High specificity and sensitivity
  • Specific detection of IgG antibodies to Borrelia burgdorferi sensu lato (sl) and in cerebro-spinal fluid (CSF) samples, to aid in the diagnosis of Neuroborreliosis*
Add to your selection

Do you need more information?

Transmitted through the bite of infected ticks, Lyme Borreliosis is the most common and rapidly spreading tick-borne disease in the world. However many of the symptoms can also occur with other diseases. VIDAS® Lyme IgM and VIDAS® Lyme IgG allow accurate, rapid, differential diagnosis to avoid misdiagnosis and help prevent progression of the disease towards severe and disabling neurological, cutaneous or articular manifestations.

Clear-cut serological profile

  • Separate IgG and IgM results to facilitate classification of Lyme Borreliosis as early or late/chronic, active or immune
  • Helps ensure patients receive rapid, optimized treatment depending on their stage of infection
  • Easy result interpretation:
    • No equivocal zone for VIDAS Lyme IgG results
    • Avoids unnecessary patient anxiety and limits additional testing

Detection of immunological response following a bite from a tick infected with Borrelia burgdorferi
Detection of immunological response following a bite from a tick
infected with Borrelia burgdorferi


High specificity and sensitivity*

  • The tests use innovative recombinant chimeric proteins* (VlsE, DbpA, OspC), allowing detection of all main pathogenic Borrelia strains
  • Less rework and confirmatory tests
  • Low level of cross-reaction with syphilis and other infectious diseases*
  • Only patients with Lyme Borreliosis are treated

High specificity and sensitivity

Performance on serum samples, for references outside US and Canada

* See package inserts for more details

Cost-effectiveness and streamlined workflow

VIDAS® Lyme IgM and VIDAS® Lyme IgG are performed on the VIDAS® automated immunoanalyzers, appreciated worldwide for their simplicity, flexibility and accuracy.

Key benefits:

  • Ease-of-use
  • Rapid results: only 27 minutes
  • Protocol compatibility between both tests
  • Single-dose format
  • Calibration only once every 28 days



  VIDAS® Lyme IgM VIDAS® Lyme IgG
Reference 30 319* 30 320*
Tests / kit 60 60
Time to result 27 minutes 27 minutes
Sample type Plasma, Serum Plasma, Serum, CSF*
Sample volume 100 µL 100 µL
Calibration frequency Every 28 days Every 28 days

* For references outside US and Canada only


Please consult your local bioMérieux representative for product availability in your country

Pioneering diagnostics